Long noncoding RNA DANCR aggravates retinoblastoma through miR-34c and miR-613 by targeting MMP-9

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Long non-coding RNAs (lncRNAs) are implicated in cancer development, but their specific roles in retinoblastoma (RB) remain unclear.
• Understanding the molecular mechanisms of lncRNAs in RB is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the biological role of the lncRNA DANCR (differentiation antagonizing non-protein coding RNA) in the carcinogenesis of human retinoblastoma.
• To elucidate the mechanism by which DANCR influences RB progression and metastasis.

Main Methods:

• Quantitative real-time PCR to assess DANCR expression in RB tissues and cell lines.
• In vitro (cell proliferation, migration, invasion assays) and in vivo (tumor xenograft) experiments to evaluate DANCR's functional impact.
• Bioinformatics analysis and luciferase reporter assays to identify and validate interactions between DANCR, microRNAs (miR-34c, miR-613), and MMP-9.

Main Results:

• DANCR was significantly upregulated in RB tissues and cell lines, correlating with poor patient survival.
• Knockdown of DANCR suppressed RB cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT).
• DANCR acted as a competing endogenous RNA (ceRNA) for miR-34c and miR-613, modulating MMP-9 expression and thereby influencing RB progression and metastasis.

Conclusions:

• DANCR plays a critical oncogenic role in retinoblastoma progression and metastasis.
• The DANCR/miR-34c/miR-613/MMP-9 axis represents a novel ceRNA mechanism in RB tumorigenesis.
• Targeting DANCR may offer a potential therapeutic strategy for retinoblastoma.